Is this news story a plus or minus for UC?

Capitol Weekly ran a story recently about the ability of UC to capture research funds from the entity voters created (and recently renewed) that floats bonds to raise money for stem cell research. 

You can judge for yourself whether the item below is a plus or minus for the university. 

They could be called the “UC Caucus,” although that may presume too much. Nonetheless, they come from an institution that has pulled down $1.2 billion from the California state stem cell agency, more than any other enterprise during the last 16 years. Not to mention that their employer — the University of California  —  is likely to snag much, much more during the next decade or so. 

The “caucus” is composed of the 13 persons with ties to the University of California (UC) who are also members of the governing board of the state’s $12 billion stem cell agency, known officially as the California Institute for Regenerative Medicine (CIRM). The UC 13 constitute the largest voting bloc on the CIRM governing board. The “caucus” includes Art Torres, who is a member of the UC Board of Regents and the salaried, vice chairman of the CIRM board of directors. Torres is a well-seasoned, former state politician with decades of vote-counting experience... 

Full story at https://capitolweekly.net/in-world-of-stem-cell-research-uc-caucus-reigns-supreme/.